Speakers - Sachs Associates

CONTACTS
Dr Rudi D Neirinckx
Chief Executive Officer
Dr Peter Burckhardt,
Board Member
ADDRESS
Hochbergerstrasse 60c
CH-4057 Basel
Switzerland
TELEPHONE
061 283 8485
FAX
061 283 8486
EMAIL
rudi_neirinckx@hotmail.com
YEAR FOUNDED
2010
Ennar Pharma AG
FINANCIAL SUMMARY
The company is financially supported by an investment by EVA- a Basel based venture capital company and by
the private funds of the founder.
COMPANY PROFILE
Ennar Pharma was founded in July 2010 to develop a better and safer topical treatment for mild-to-moderate
psoriasis. Patents, protecting the technology, have been granted in Europe and the USA. The company is
financially supported by an investment by EVA- a Basel based venture capital company- and uses a network
of strategic partners to develop the production of EGF and develop a suitable cream-based pharmaceutical
product. Producers for the cGMP production of high-quality EGF(epidermal growth factor) and for a stable
cream formulation of the active ingredient have been contracted and a Proof-of-Concept trial is running at the
Dermatology Clinic of the University of Zurich. The trial, which is carried out with mild-to-moderate psoriasis
patients, aims to establish the validity of the mode-of-action proposed for the EGF-based topical formulation and
test an optimised formulation for clinical efficacy and safety. Results of the trial are expected in Q1 2013.
MANAGEMENT
Dr Rudi D Neirinckx, Chief Executive Officer
Dr Peter Burckhardt, Board Member
t back :: next u
WELCOME PHARMA LICENSING GROUPS
SPEAKERS
PRESENTING COMPANIES SUPPORTING ORGANISATIONS
ORGANISERS